10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the fourth quarter and full year ended December 31, 2024 after market ...
20:39 EST Cathie Wood’s ARK Investment buys 77.6K shares of 10x Genomics (TXG) today Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks ...
Cathie Wood recently made a significant investment in 10x Genomics Inc. (NASDAQ:TXG), with ARK purchasing 247,089 shares and investing $3,666,800 across its ARKK and ARKG ETFs. Wood’s belief ...
10x Genomics (NASDAQ:TXG ... As investors shy away from the name, Cathie Wood has shown a willingness to step in as a contrarian, most recently purchasing shares in the $14-16 range.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...
Barclays lowered the firm’s price target on 10x Genomics to $18 from $19 and keeps an Overweight rating on the shares. The firm expects the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results